Editorial introductions

Current Opinion in Endocrinology and Diabetes was launched in 1994. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal’s Section Editor for this issue. SECTION EDITORS Bruce G. Robinson, MD Professor Robinson is an Endocrinologist and Head of the Cancer Genetics Laboratory in the Kolling Institute. He is also Head of the Division of Medicine at the Royal North Shore Hospital. Professor Robinson graduated from the University of Sydney in 1980 and then undertook studies for a Masters of Science degree. His further molecular research work was performed at the Brigham and Women’s Hospital and the Children’s Hospital, Harvard Medical School from 1986 to 1989 and he was awarded a Doctorate of Medicine from the University of Sydney in 1990. He has developed the Cancer Genetics Laboratory since 1990 and has supervised over 20 doctoral and masters students working on the genetic basis for tumour formation and gene therapy. In 2003, Professor Robinson was awarded the Daiichi Prize by the Asia and Oceania Thyroid Association for his work on the pathogenesis of thyroid cancer. Professor Robinson is Associate Dean (International), Faculty of Medicine, at the University of Sydney and also serves on the Council of the Endocrine Society of Australia. He is on the Editorial Board of the international journal Thyroid. He also is Founding Chairman of Hoc Mai, the Australia Vietnam Medical Foundation, which sponsors and supports medical, nursing, allied health and scientific exchanges between Australia and Vietnam. Aaron Vinik, MD, PhD, FCP, FACP.FACE Dr. Vinik has brought international recognition to Virginia because of his research and recent discovery of a gene which could prove to be a cure for diabetes. The gene, INGAP (islet neogenesis associated protein) is responsible, either alone or in combination with other factors, for stimulating immature cells in the diabetic pancreas to produce insulin. INGAP protein has been administered to diabetic hamsters and has been shown to reverse diabetes in 40% to 50% of animals. The discover has far reaching implications: it could free the two million people with type I diabetes from daily injections of insulin; it could help the 20 million people with type 2 diabetes whose pancreas ultimately fails; and, it could be used in genetic screening to identify those predisposed for developing diabetes. The discovery is a result of 16 years of perseverance, committed to the belief (thought by many to be heretical) that islets could be made to grow. The success in finding the INGAP gene follows years of success in research and treatment of neuropathy, a complication of diabetes. Dr. Vinik is a national leader in basic and clinical neuropathy. He, in essence, has defined the heterogeneity of neuropathy, established a need for a modular approach depending on the particular nerve fiber damaged, and pioneered studies on the relationship between neuropathy, autoimmunity, and cell toxicity. His advances in the understanding of neuropathy have resulted in patient treatment referrals from all parts of the United States and many other countries. He has been listed amongst the best physicians in USA for the past nine years. Dr. Vinik has been invited to present his work all over the world. Recognized as a pioneer and a scholar, Dr. Vinik has authored five books, one devoted to islet regeneration, 75 book chapters, and has published more than 300 papers in peer-reviewed, highly reputable journals. He has also published more than 260 abstracts and he and the fellows he has trained have presented scientific papers at innumerable national and international meetings. He has been invited to give the Banting Lecture at the University of Toronto, the Minkowski Lecture in Kaunas, Lithuania and the “INGAP Story” in Helsingor, Denmark, at the International Pancreatic Islet Symposium. He has been “Meet the Professor” at the Endocrine Society, American Diabetes Association, and American College of Physicians. Dr. Vinik received the Dean’s Award for Outstanding Research in 1993, Dean’s Award for Outstanding Faculty in 1999 and the Virginia Outstanding Scientist 2002. Dr. Vinik is a member of a number of professional societies including the American Endocrine, Diabetes, Gastroenterology, and the European and International Diabetes associations. Dr. Vinik was a member of the National Institute of Health General Clinical Research Center Study Section and the NIH Data Management committee. He was also Chairman of the American Diabetes Association task force on Nutrition, which established the guidelines for nutritional management of diabetes, and Chairman of the subcommittee for development of guidelines for neuropathy testing; in addition, he was a member of the committee to develop guidelines for managing lipid disorders in diabetes. He is Chairperson of the American Diabetes Association Grant Review Committee and Director of the National Post-Graduate Education Course. Dr. Vinik has received research funding for his studies from the National Institutes of Health, the National Cancer Institute, the Kroc Foundation, the American Diabetes Association, HUD, NASA, The Diabetes Institutes Foundation, and pharmaceutical industries. Dr. Vinik holds three issued patents; six more patents are being studied. He holds the copyright for the Quality of Life tool for assessing lifestyle problems in diabetic neuropathy.Figure.Figure.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.